
Methermat 0.2mg Injection
Marketer
Makers Laboratories Ltd
Salt Composition
Ergotamine (0.2mg)
Overview Methermat 0.2mg Injection
Migralax 0.2mg injection is a prescription medication for acute migraine management. It works by constricting blood vessels, thus alleviating migraine pain. Migralax 0.2mg is administered orally, with or without food, ideally at bedtime. Consistent daily timing ensures stable blood levels. Complete the prescribed course, even with symptom improvement; avoid missed doses. If a dose is forgotten, take it immediately upon recollection. Continue treatment as directed by your physician; abrupt cessation may exacerbate headaches. Potential side effects include nausea, vomiting, myalgia, and lower limb pain. Dizziness is possible; refrain from driving or operating equipment until the drug's effects are known.
Primary Ingredients of Methermat 0.2mg Injection
No information provided. Unable to rephrase.
Uses of Methermat 0.2mg Injection
Severe, sudden migraine attack
Major Benefits of Methermat 0.2mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Methermat 0.2mg Injection:
- Nausea
- Vomiting
- Muscle pain
- Leg pain
How to use Methermat 0.2mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Methermat 0.2mg Injection works:
The dilation of cranial blood vessels is believed to trigger migraine headaches. Methermat 0.2mg Injection, a serotonin receptor blocker, counteracts this by regulating brain serotonin levels, thereby interrupting pain signals. It further suppresses the production of pro-inflammatory neuropeptides—chemical messengers contributing to migraine pain. Finally, its action on 5-HT1D receptors constricts blood vessels, providing additional pain relief.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Methermat 0.2mg Injection may pose unknown risks. Physician consultation is advised.
PregnancyUNSAFE
Administering Methermat 0.2mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, as research in both animal and human subjects indicates considerable adverse effects on fetal development.
Breast feedingUNSAFE
Administration of Methermat 0.2mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Administration of Methermat 0.2mg Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Methermat 0.2mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Methermat 0.2mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Methermat 0.2mg Injection :
Should you forget a Methermat 0.2mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Methermat 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Ergot Alkaloid |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
| Actions | Ergot alkaloid |
